Search Results - "Arolt, C"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Recurrence after primary salivary gland carcinoma: Frequency, survival, and risk factors by Nachtsheim, Lisa, Jansen, L, Shabli, S, Arolt, C, Quaas, A, Klussmann, J P, Mayer, M, Wolber, P

    Published in Head & neck (27-07-2024)
    “…Primary salivary gland carcinomas (SGC) are rare neoplasms that present therapeutic challenges especially in recurrent tumors. The aim of this study was to…”
    Get full text
    Journal Article
  2. 2

    Incidence and clinical outcome of primary carcinomas of the major salivary glands: 10-year data from a population-based state cancer registry in Germany by Nachtsheim, Lisa, Mayer, M., Meyer, M. F., Oesterling, F., Kajueter, H., Arolt, C., Quaas, A., Klussmann, J. P., Wolber, P.

    “…Purpose The aim of this project was to provide an overview of the epidemiology of primary salivary gland carcinomas (SGC) in terms of incidence, distribution…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Expression of Mucins in Different Entities of Salivary Gland Cancer: Highest Expression of Mucin-1 in Salivary Duct Carcinoma: Mucin-1 – highest expression in Salivary Duct Carcinoma by Wolber, P., Mayer, M., Nachtsheim, L., Prinz, J., Klußmann, J. P., Quaas, A., Arolt, C.

    Published in Head & neck pathology (Totowa, N.J.) (01-09-2022)
    “…Therapeutic options for advanced salivary gland cancer (SGC) are rare. Therefore, it was the aim of this study to investigate the extent and intensity of…”
    Get full text
    Journal Article
  5. 5

    Tumor microenvironment in salivary gland carcinomas: Consequences for new therapeutic concepts by Meyer, M F, Arolt, C, Kansy, B A, Doescher, J, Quaas, A, Beutner, D, Lang, S, Klußmann, J P

    Published in HNO (01-12-2020)
    “…Salivary gland carcinomas (SGCs) are rare tumors which represent a challenge for diagnosis and therapy due to their histological diversity and the different…”
    Get full text
    Journal Article
  6. 6

    Das Tumormikromilieu bei Speicheldrüsenkarzinomen – mögliche Konsequenzen für neue Therapiekonzepte by Meyer, M. F., Arolt, C., Kansy, B. A., Doescher, J., Quaas, A., Beutner, D., Lang, S., Klußmann, J. P.

    Published in HNO (01-12-2020)
    “…Zusammenfassung Hintergrund Speicheldrüsenkarzinome („salivary gland carcinomas“, SGC) sind seltene Tumoren, die aufgrund ihrer histologischen Vielfalt und den…”
    Get full text
    Journal Article